Multi-protein complexes, rather than single proteins acting in isolation, often govern molecular pathways regulating cellular homeostasis. Based on this principle, the purification of critical proteins required for the functioning of these pathways along with their native interacting partners has not only allowed the mapping of the protein constituents of these pathways, but has also provided a deeper understanding of how these proteins coordinate to regulate these pathways. Within this context, understanding a protein's spatiotemporal localization and its protein-protein interaction network can aid in defining its role within a pathway, as well as how its misregulation may lead to disease pathogenesis. To address this need, several approaches for protein purification such as tandem affinity purification (TAP) and localization and affinity purification (LAP) have been designed and used successfully. Nevertheless, in order to apply these approaches to pathway-scale proteomic analyses, these strategies must be supplemented with modern technological developments in cloning and mammalian stable cell line generation. Here, we describe a method for generating LAP-tagged human inducible stable cell lines for investigating protein subcellular localization and proteinprotein interaction networks. This approach has been successfully applied to the dissection of multiple cellular pathways including cell division and is compatible with high-throughput proteomic analyses.
Introduction
To investigate the cellular function of an uncharacterized protein it is important to determine its in vivo spatiotemporal subcellular localization and its interacting protein partners. Traditionally, single and tandem epitope tags fused to the N or C-terminus of a protein of interest have been used to facilitate protein localization and protein interaction studies. For example, the tandem affinity purification (TAP) technology has enabled the isolation of native protein complexes, even those that are in low abundance, in both yeast and mammalian cell lines 1, 2 . The localization and affinity purification (LAP) technology, is a more recent development that modifies the TAP procedure to include a localization component through the introduction of the green fluorescent protein (GFP) as one of the epitope tags 3 . This approach has given researchers a deeper understanding of a protein's subcellular localization in living cells while also retaining the ability to perform TAP complex purifications to map protein-protein interaction networks.
However, there are many issues associated with the use of TAP/LAP technologies that has hampered their widespread use in mammalian cells. For example, the length of time that is necessary to generate a stable cell line expressing a TAP/LAP tagged protein of interest; which typically relies on cloning the gene of interest into a viral vector and selecting single cell stable integrants with the desired expression level. Additionally, many cellular pathways are sensitive to constitutive protein overexpression (even at low levels) and can arrest cells or trigger cell death over time making the generation of a TAP/LAP stable cell line impossible. These and other constraints have impeded LAP/TAP methodologies from becoming high-throughput systems for protein localization and protein complex elucidation. Therefore, there has been considerable interest in the development of an inducible high-throughput LAP-tagging system for mammalian cells that takes advantage of current innovations in cloning and cell line technologies.
Here we present a protocol for generating stable cell lines with Doxycycline/Tetracycline (Dox/Tet) inducible LAP-tagged proteins of interest that applies advances in both cloning and mammalian cell line technologies. This approach streamlines the acquisition of data with regards to LAPtagged protein subcellular localization, protein complex purification and identification of interacting proteins . Additionally, the ORFeome collaboration has cloned thousands of sequence validated open reading frames in vectors that incorporate these advances in cloning, which are available to the scientific community [8] [9] [10] [11] . In our system, the pGLAP1 LAP-tagging vector enables the simultaneous cloning of a large number of clones, which facilitates high-throughput LAP-tagging. This expedited cloning procedure is coupled to a streamlined approach for generating cell lines with LAP-tagged genes of interest inserted at a single pre-determined genomic locus. This makes use of cell lines that contain a single flippase recognition target (FRT) site within their genome, which is the site of integration for LAP-tagged genes. These cell lines also express the tetracycline repressor (TetR) that binds to Tet operators (TetO 2 ) upstream of the LAPtagged genes and silences their expression in the absence of Dox/Tet. This allows for Dox/Tet inducible expression of the LAP-tagged protein at any given time. Having the capability of inducible LAP-tagged protein expression is critical, since many cellular pathways are sensitive to the levels of critical proteins governing the pathway and can arrest cell growth or trigger cell death when these proteins are constitutively overexpressed, even at low levels, making the generation of non-inducible LAP-tagged stable cell lines impossible 12 .
Protocol
NOTE: An overview of the generation of inducible LAP-tagged stable cell lines for any protein of interest is illustrated in Figure 1 and the overview of LAP-tagged protein expression, purification and preparation for mass proteomic analyses is illustrated in 
Cloning the Open Reading Frame (ORF) of the Gene of Interest into the LAP-tag Vector
1. Cloning the ORF of the Gene of Interest into the Shuttle Vector.
1. Use polymerase chain reaction (PCR) to amplify the ORF of interest with the appropriate attB1 and attB2 sites within the primers for either N-terminal fusion or C-terminal fusion. See Table 1 for primer sequences and Table 2 for PCR conditions. 2. Gel purify the PCR products by resolving them on a 1% agarose gel. Excise the amplified band that is the correct size from the gel and extract it from the gel slice using a DNA gel extraction kit as per manufacturer's instructions. 3. Incubate the purified attB containing PCR products with an attP containing shuttle vector and the recombinase that allows the PCR products to recombine into the vector as per manufacturer's instructions (see Materials Table) . NOTE: Empty shuttle vectors and LAP-tagging vectors contain the ccdB gene and have to be propagated in ccdB resistant bacterial cells (see Materials Table) . However the ccdB gene is recombined out when an ORF is inserted into these vectors, hence use standard DH5α E. coli cells when propagating vectors with cloned ORFs. 4. Transform DH5α E. coli cells with 1 μl of the reaction product and plate the transformed cells onto a Luria broth (LB) agar plate with 50 mg/ml Kanamycin 13 . 5. Select the Kanamycin resistant colonies. 6. Grow the selected colonies in LB media with 50 mg/ml Kanamycin, make a DNA mini-prep and confirm gene integration by DNA sequencing using the sequencing primers listed in Table 3 .
2.
Transferring the Gene of Interest from the Shuttle Vector into the LAP-tag Vector. 1. Incubate the shuttle vector containing the sequence verified gene of interest ORF with the LAP-tag vector (pGLAP1 for N-terminal fusion) and the recombinase that mediates the transfer of the gene of interest from the shuttle vector into the LAP-tag vector as per manufacturer's instructions (see Materials). NOTE: A series of LAP/TAP vectors that can be used based on the desired promoter, epitope-tag, and N or C-terminal tagging can be found in Table 4 . 2. Transform DH5α E. coli cells with 1 μl of the reaction product and plate the transformed cells onto an LB agar plate with 100 mg/ml Ampicillin 13 . 3. Select the Ampicillin resistant colonies. 4. Grow the selected colonies in LB media with 100 mg/ml Ampicillin, make a DNA mini-prep, and confirm gene integration by DNA sequencing using the sequencing primers listed in Table 5 .
NOTE:
The FRT containing HEK293 cell line also contains the TetR that is associated with Blasticidin resistance, therefore 5 µg/ml Blasticidin is used during the stable cell line selection process to select for the TetR and to minimize leaky expression. 6. Replace Hygromycin-containing -Tet DMEM/F12 media as needed until distinct cell foci appear that resemble opaque spots against the transparent plate. 7. Add 20 μl of trypsin on top of each cell foci and pipet up and down 2 times with a 200 μl pipet tip. Place cells in a 24 well plate and expand the cells by continual growth in Hygromycin-containing -Tet DMEM/F12 media. 8. Screen cells for inducible LAP-tagged protein expression by fixed-cell or live-cell fluorescence microscopy and/or Western blotting for the GFP tag within the LAP-tag 15 .
Purification of LAP-tagged Protein Complexes
NOTE: The following LAP-tagged protein purification protocol details recommendations on conditions and volumes used for a typical LAP-tagged protein purification based on previous experience. However, caution should be exercised to ensure that empirical optimization is carried out for any protein complex and protein expression level of interest to provide the best results.
1. Cell Growth and Cell Harvesting. 1. Expand the validated LAP-tagged cell line for TAP isolation of protein complexes, by continually passaging all HEK293 cells into larger plates and/or roller bottles in -Tet DMEM/F12 media at 37 °C and 5% CO 2 . 2. For Tet/Dox inducible cell lines, induce for 10-15 hr at a concentration of 0.2 µg/ml Tet/Dox when the cells reach ~70% confluency, before harvesting cells. NOTE: The concentration and induction time should be determined for each protein, a titration of 0.1-1 µg/ml Tet/Dox for 10-15 hr is recommended. 3. Harvest cells by agitation or trypsinization and pellet cells at 875 x g for 5-10 min.
Coupling Anti-GFP Antibody to Protein A Beads
1. Use 40 µg of antibody for immunoprecipitation from a lysate prepared from a 0.5 ml cell pellet, packed cell volume (PCV). NOTE: The amount of antibody needed will depend on the abundance of the LAP-tagged protein, among other factors, and will require optimization. A titration of 10-40 µg is recommended. 2. Equilibrate 160 µl packed volume (PV) Protein A beads into PBST (PBS + 0.1% Tween-20) in a 1.5 ml tube. Wash 3 times with 1 ml of PBST. NOTE: All washes herein are carried out by centrifuging the beads at 5,000 x g for 10 sec. 3. Resuspend beads in 500 µl PBST and add 80 µg of affinity-purified rabbit anti-GFP antibody to each tube of 160 µl beads. Mix for 1 hr at room temperature (RT). 4. Wash beads 2 times with 1 ml of PBST. Then, wash beads 2 times with 1 ml of 0. NOTE: Nonyl phenoxypolyethoxylethanol is a mild detergent that solubilizes proteins, but preserves protein-protein interactions, thus a higher concentration is used during the extraction process and it is then lowered during the binding and washing steps. 
Preparation of Buffers for Cell Lysis and

Identify Interacting Proteins by Mass Spectrometry Analysis
1. Test the quality of the purification by analyzing the collected samples by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), silver staining the gel (see Materials Table) and by immunoblotting the eluates and probing with anti-GFP antibodies to ensure that the LAP-tagged purification worked 16 , see Figure 4 . 2. To identify stoichiometric and substoichiometric co-purifying species, take the final elution sample and separate it by SDS-PAGE. Stain the gel with a mass spectrometry compatible protein stain. Excise the most prominent bands and the space in between them from the gel and process them for analysis by mass spectrometry separately 16 . NOTE: There are numerous approaches for separating the final purification eluates and preparing them for mass spectrometry 5 . For example, LAP-purified complexes can be eluted from S-protein beads by using high salt (3.5 M MgCl 2 ) and the entire protein population en masse can be analyzed by mass spectrometry 17 . Alternatively, final eluates can be separated for 1 mm by SDS-PAGE and a single 1 mm band can be excised and analyzed. This clears the complex mixture of any beads or particulate matter that will interfere with the analysis.
Representative Results
To highlight the utility of this system, the open reading frame (ORF) of the Tau microtubule binding protein was cloned into the shuttle vector by amplifying the Tau ORF with primers containing attB1 and attB2 sites ( Table 1 ) and incubating the PCR products with the shuttle vector and a recombinase that mediates the insertion of the PCR products into the shuttle vector. The reaction products were used to transform DH5α bacteria 13 and plasmid DNA from Kanamycin resistant colonies was sequenced to ensure Tau insertion. A sequence validated shuttle-Tau vector was then used to transfer the Tau ORF into the pGLAP1 vector, which fused Tau in frame with the LAP (EGFP-TEV-S-Protein) tag, by incubating the shuttle-Tau vector with the pGLAP1 vector and the recombinase that mediates the transfer of the ORF from the shuttle vector to pGLAP1. The reaction products were used to transform DH5α bacteria 13 and plasmid DNA from Ampicillin resistant colonies was sequenced to ensure that the LAP-Tau fusion was in frame. Sequence validated pGLAP1-LAP-Tau was then co-transfected with a vector that expresses the flippase recombination enzyme into HEK293 cells that contained a single flippase recognition target (FRT) site within their genome, which is the site of integration for LAP-tagged genes 14 . This cell line also expressed the TetR that binds to Tet operators upstream of the LAP-tagged genes and silences their expression in the absence of Tet/Dox. Stable integrants were selected with -Tet DMEM/F12 media with 100 µg/ml Hygromycin for 5 days. Individual Hygromycin resistant cell foci were harvested by adding 20 µl of trypsin on top and pipetting up and down 2 times. Cells were placed in a 24 well plate and expanded by continual growth in -Tet DMEM/F12 media.
To verify that the Hygromycin resistant cells were capable of expressing LAP-Tau, HEK293 LAP-Tau cells were induced with 0.1 µg/ml Dox for 15 hr and protein extracts were prepared from non-induced and Dox-induced cells. These extracts were separated by SDS-PAGE, transferred to a PVDF membrane, and immunoblotted for GFP and Tubulin as loading control. As seen in Figure 4A , LAP-Tau (visualized with anti-GFP antibodies) was only expressed in the presence of Dox. To validate that LAP-Tau was properly localized to the mitotic microtubule spindle during mitosis, as had been previously shown for endogenous Tau 18 , HEK293 LAP-Tau cells were induced with 0.1 µg/ml Dox for 15 hr and cells were fixed with 4% paraformaldehyde and co-stained for DNA (Hoechst 33342) and microtubules (anti-Tubulin antibodies). Consistently, LAP-Tau was localized to the mitotic spindle during metaphase of mitosis (Figure 4B) . To verify that LAP-Tau and its interacting proteins could be purified with this system, HEK293 LAP-Tau cells were grown in roller bottles to ~70% confluency, induced with 0.1 µg/ml Dox for 15 hr, harvested by agitation, lysed with LAP300 buffer, and LAP-Tau was purified using the above protocol. Eluates from the LAP-Tau purification were resolved by SDS-PAGE and the gel was silver stained. Figure 4C shows the LAP-Tau purification, marked with an asterisk is LAP-Tau and several other bands indicative of Tau interacting proteins can be seen. Table 1 ) and cloned into the shuttle vector. Sequence verified shuttle vectors with the gene of interest are then used to transfer the gene of interest into the pGLAP1 vector. The sequence verified pGLAP1 vector with the gene of interest is then co-transfected with the vector containing the flippase recombinase into the desired cell line that contains a single flippase recognition target (FRT) site within their genome, which is the site of integration for LAP-tagged genes. These cell lines also express the Tet repressor (TetR) that binds to Tet operators (TetO 2 ) upstream of the LAP-tagged genes and silences their expression in the absence of Tet/Dox. The LAP-tagged gene of interest is then recombined into the FRT site and stable integrants are selected with Hygromycin. Please click here to view a larger version of this figure. 
N-terminal fusion
pGLAP1 5'- ATCACTCTCGGCATGGACGAGCTGTACAAG-3' 5'- TGGCTGGCAACTAGAAGGCACAGTCGAGGC-3' pGLAP2 5'-CGAACGCCAGCACATGGACAGGG-3' 5'- TGGCTGGCAACTAGAAGGCACAGTCGAGGC-3' pGLAP3 5'-AGAAACCGCTGCTGCTAA-3' 5'-TAGAAGGCACAGTCGAGG-3' pGLAP4 5'-AGACCCAAGCTGGCTAGGTAAGC-3' 5'-TAGAAGGCACAGTCGAGG-3' pGLAP5 5'-CGTAATACGACTCACTATAG-3' 5'-TCCAGGGTCAAGGAAGGCACGG-3'
Discussion
The outlined protocol describes the cloning of genes of interest into the LAP-tagging vector, the generation of inducible LAP-tagged stable cell lines, and the purification of LAP-tagged protein complexes for proteomic analyses. With respect to other LAP/TAP-tagging approaches, this protocol has been streamlined to be compatible with high-throughput approaches to map protein localization and protein-protein interactions within any cellular pathway. This approach has been widely applied to the functional characterization of proteins critical for cell cycle progression, mitotic spindle assembly, spindle pole homeostasis, and ciliogenesis to name a few and has aided the understanding of how misregulation of these proteins can lead to human diseases 15, 16, 19, 20 . For example, our group recently utilized this system to define the function and regulation of the STARD9 mitotic kinesin (a candidate cancer target) in spindle assembly 15, 21 , to define a new molecular link between the Tctex1d2 dynein light chain and short rib polydactyly syndromes (SRPS) 19 , and to define a new molecular link to understanding how mutation of the Mid2 ubiquitin ligase can lead to X-linked intellectual disabilities 16 . Other laboratories have also successfully applied this method, including one that determined that Tctn1, a regulator of mouse Hedgehog signaling, was a part of a ciliopathy-associated protein complex that regulated ciliary membrane composition and ciliogenesis in a tissue-dependent manner 22, 23 . Therefore, this protocol can be broadly applied to the dissection of any cellular pathway.
A critical step in this protocol is the selection of LAP-tagged stable cell lines that are Hygromycin resistant. Special care should be taken to ensure that all cells in the control plate are dead before selecting foci in the experimental plate for amplification. Hygromycin can also be added during routine cell culturing of LAP-tagged stable cell lines to further ensure that all cells maintain the LAP-tagged gene of interest at the FRT site. We caution that not all LAP-tagged proteins will be functional and that it is important to have assays in place that can be used to test protein function. Examples of assays used to test protein function include the rescue of siRNA-induced phenotypes and in vitro activity assays. To address any potential problems with the addition of a large LAP-tag, we have previously generated TAP-tag vectors compatible with this system that contain smaller tags, like FLAG, which are less likely to inhibit the function and localization of the protein of interest 4 .
In addition, LAP-tagging vectors exist for generating C-terminal LAP-tagged proteins or C-terminal TAP-tagged proteins that are compatible with this system, which can be used in cases where a LAP/TAP tag is not tolerated at the N-terminus of a protein. Additionally, the salt and detergent concentrations of the purification buffers (LAPX N ) can be modified to increase or decrease the purification stringency if none or too many interactions are observed. Similarly, the tandem affinity purification procedure is more stringent than single purification procedures and weak interactors may be lost, thus a single purification scheme can be used when few or no interactors are identified.
It is important to note that other GFP epitope tagging approaches exist that allow large scale GFP protein tagging for protein localization and purification studies 24, 25 . These include the BAC TransgenOmics approach that utilizes bacterial artificial chromosomes to express GFP-tagged genes of interest from their native environment that contains all the regulatory elements, which mimics endogenous gene expression 24 . More recently, CAS9/single-guided RNA (sgRNA) ribonucleoprotein complexes (RNPs) have been used to endogenously tag genes of interest with a split-GFP system that allows the expression of GFP-tagged genes from their endogenous genomic loci It is also important to note that other tagging systems can also be modified to become compatible with the system described here for generating inducible epitope-tagged stable cell lines. For example, proximity-dependent biotin identification (BioID) has garnered considerable attention due to its ability to define spatial and temporal relationships among interacting proteins 26 . This technique exploits protein fusions to a promiscuous strain of the Escherichia coli biotin ligase BirA, which biotinylates any protein within a ~10 nm radius of the enzyme. The biotinylated proteins are then affinity purified using biotin-affinity capture and analyzed for composition by mass spectrometry. BirA will biotinylate any protein in close proximity, even transiently, which makes it especially suited for detecting weaker interacting partners within a complex 27 . Additionally, the purification scheme does not necessitate that endogenous protein-protein interactions remain intact and can be carried out under denaturing conditions, thus reducing the rate of false positives. Within our current protocol, the substitution of the pGLAP1 vector by a BirA-tagging vector could transform this system from identifying protein-protein interactions based on affinity to detecting them based on proximity. Such a system would be highly advantageous for detecting transient protein interactions as is the case between many enzyme-substrate interactions and for mapping the spatiotemporal protein-protein interactions within defined structures as has been carried out for the centrosome and cilia 26, 28 .
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